Georgia Start-Up Gets Federal Funding for Nasal COVID Vaccine Trial
A University of Georgia-based start-up, CyanVac LLC, announces it will commence a clinical trial for a nasal COVID-19 vaccine this fall, bolstered…
A University of Georgia-based start-up, CyanVac LLC, announces it will commence a clinical trial for a nasal COVID-19 vaccine this fall, bolstered…